Siyata Mobile's 15min Chart Triggers MACD Death Cross, KDJ Death Cross

According to the technical analysis of Siyata Mobile's 15-minute chart, the MACD Death Cross and KDJ Death Cross occurred on July 23, 2025, at 12:45. This suggests that the stock price has a high potential to continue declining, and the momentum of the stock price is shifting towards the downside, indicating a further decrease in value.

Alkermes plc (ALKS) has reported encouraging results from its Vibrance-1 phase 2 study evaluating alixorexton in patients with narcolepsy type 1 (NT1). The study met its primary goal, demonstrating statistically significant and clinically meaningful improvements in wakefulness compared to placebo. Additionally, alixorexton showed robust improvements in patient-reported outcomes related to excessive daytime sleepiness, fatigue, and cognition. The drug candidate was generally well-tolerated at all tested doses [1].

These positive findings support the rapid initiation of a phase 3 program for alixorexton in patients with NT1. The company's progress in developing a potential treatment for narcolepsy is a promising development in the field of neurological disorders.

References:
[1] https://www.nasdaq.com/articles/alkermes-vibrance-1-phase-2-study-alixorexton-narcolepsy-type-1-meets-primary-goal